KPMG, a firm that provides business solutions and audit, tax, and advisory services, released the results of its Health Care & Life Sciences Investment Outlook survey. The survey finds that healthcare and life sciences investment professionals believe the volume of deals will grow in most sectors in 2020 compared to last year. However, they also believe that upcoming elections could impact the investment outlook.
Nearly half of investors surveyed anticipate that the 2020 election could have a potentially negative impact on investment activity in healthcare (48%) and life sciences (47%). Only 19% of investors surveyed expect the election leading to increased investment in healthcare, and 13% of investors surveyed said the same for life sciences.
Read the full report here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.